BMP4 and glioblastoma: Indeed, an integrative study of mRNA and protein levels at single-cell resolution evaluating the effect of BMP4 (a proposed therapeutic agent for glioblastoma [362]) on early-passage glioblastoma cultures [363] identified extensive heterogeneity in how subpopulations of cells respond to BMP4 treatment.